NasdaqCM - Nasdaq Real Time Price USD
Edesa Biotech, Inc. (EDSA)
2.3100
-0.0500
(-2.12%)
As of 11:47:45 AM EDT. Market Open.
Breakdown
TTM
9/30/2024
9/30/2023
9/30/2022
9/30/2021
Operating Cash Flow
-5,000.8800
-4,890.2050
-6,636.4830
-12,279.3020
-13,664.9320
Investing Cash Flow
--
--
--
-5.6560
-6.1460
Financing Cash Flow
2,357.8340
592.0310
4,830.1110
11,629.6280
14,174.7410
End Cash Position
1,624.7410
1,037.3200
5,361.3970
7,090.9190
7,839.2590
Capital Expenditure
-34.3390
--
--
-5.6560
-6.1460
Issuance of Capital Stock
2,581.7660
729.3870
4,345.0170
11,957.6870
12,662.3570
Repayment of Debt
--
-29.5320
--
--
--
Free Cash Flow
-5,000.8800
-4,890.2050
-6,636.4830
-12,284.9580
-13,671.0780
9/30/2021 - 6/21/2010
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
TSBX Turnstone Biologics Corp.
0.3000
-5.63%
SONN Sonnet BioTherapeutics Holdings, Inc.
1.3618
-4.10%
IMRN Immuron Limited
1.8625
+5.23%
NKGN NKGen Biotech, Inc.
0.1229
+0.49%
MBIO Mustang Bio, Inc.
1.1897
-10.55%
KPRX Kiora Pharmaceuticals, Inc.
3.1800
+0.63%
TXTM ProText Mobility, Inc.
0.0007
-12.50%
ZVSA ZyVersa Therapeutics, Inc.
0.7350
+4.39%
REVB Revelation Biosciences, Inc.
2.8500
+0.71%
MBRX Moleculin Biotech, Inc.
1.0800
+4.86%